Keyword Analysis & Research: askbio
Keyword Research: People who searched askbio also searched
Search Results related to askbio on Search Engine
-
AskBio - AAV Gene Therapy Technology & Therapeutics
https://www.askbio.com/
WEBAskBio is a leading, clinical-stage gene therapy company dedicated to developing AAV gene therapies for genetic and complex disorders. Learn more about our gene therapy technology and current clinical trials.
DA: 9 PA: 75 MOZ Rank: 36
-
AAV Gene Therapy Clinical Pipeline | AskBio
https://www.askbio.com/gene-therapy-pipeline/
WEBLearn more about AskBio's gene therapy pipeline for neuromuscular, CNS and cardiovascular genetic disorders including Pompe, limb-girdle muscular dystrophy 2i, Multiple Systems Atrophy (MSA), Huntington's disease, Parkinson's disease and …
DA: 10 PA: 93 MOZ Rank: 12
-
Ask Bio - a Gene Therapy Company in RTP, North Carolina
https://www.askbio.com/who-we-are/
WEBWe became a wholly owned, independently operated subsidiary of Bayer AG in late 2020 as a cornerstone of its newly formed Cell & Gene Therapy Platform. AskBio is headquartered in Research Triangle Park, North Carolina, a thriving biotechnology hub with nearly 600 life science companies.
DA: 69 PA: 72 MOZ Rank: 66
-
AskBio presents 18-month Phase Ib trial results of AB-1005 gene …
https://www.askbio.com/askbio-presents-18-month-phase-ib-trial-results-of-ab-1005-gene-therapy-for-patients-with-parkinsons-disease/
WEB2 days ago · AskBio’s gene therapy platform includes Pro10™, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter library. With global headquarters in Research Triangle Park, North Carolina, and European headquarters in Edinburgh, Scotland, the company has generated hundreds of …
DA: 94 PA: 22 MOZ Rank: 89
-
Bayer Acquires AskBio to Broaden Innovation Base in Cell and …
https://www.askbio.com/bayer-acquires-askbio-to-broaden-innovation-base-in-cell-and-gene-therapy/
WEBOct 26, 2020 · Berlin, Germany and Research Triangle Park, N.C. – October 26, 2020 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio) today announced an agreement under which Bayer will acquire AskBio, a U.S.-headquartered biopharmaceutical company specializing in the research, development and manufacturing of gene therapies across …
DA: 26 PA: 99 MOZ Rank: 72
-
Asklepios BioPharmaceutical, Inc. (AskBio) | LinkedIn
https://www.linkedin.com/company/askbio
WEBAbout us. Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing...
DA: 51 PA: 88 MOZ Rank: 93
-
Patient-Centered Gene Therapy Clinical Trials | AskBio
https://www.askbio.com/gene-therapy-clinical-trials/
WEBPatient-Centered Gene Therapy Clinical Trials | AskBio. Learn about our AAV gene therapy clinical trials. While we help raise awareness of clinical research opportunities, enrolling physicians are responsible for screening potential patients and confirming their eligibility.
DA: 37 PA: 11 MOZ Rank: 65
-
AskBio Phase Ib trial of AB-1005 gene therapy in patients with
https://www.askbio.com/askbio-phase-ib-trial-of-ab-1005-gene-therapy-in-patients-with-parkinsons-disease-meets-primary-endpoint/
WEBJan 4, 2024 · AskBio Phase Ib trial of AB-1005 gene therapy in patients with Parkinson’s disease meets primary endpoint. AB-1005 (AAV2-GDNF), an investigational gene therapy for the treatment of Parkinson’s disease, was well tolerated with no attributed serious adverse events in all 11 patients at 18 months.
DA: 96 PA: 51 MOZ Rank: 13
-
Gene Therapy For Parkinson’s disease | AskBio
https://www.askbio.com/genetic-disease-focus/parkinsons-disease/
WEBBy enhancing levels of a naturally occurring growth factor, glial cell line-derived neurotrophic factor (GDNF) gene therapy is intended to promote the survival and functioning of vulnerable brain cells that degenerate in Parkinson’s disease.
DA: 27 PA: 85 MOZ Rank: 69
-
AskBio presents 18-month Phase Ib trial results of AB-1005 gene …
https://finance.yahoo.com/news/askbio-presents-18-month-phase-120300311.html
WEB1 day ago · Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, on Sunday April 14 presented results from the ...
DA: 64 PA: 21 MOZ Rank: 24
